Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Predicting Romantic Interest at Zero Acquaintance: Evidence of Sex Differences in Trait Perception but Not in Predictors of Interest.

Olderbak SG, Malter F, Wolf PSA, Jones DN, Figueredo AJ.

Eur J Pers. 2017 Jan-Feb;31(1):42-62. doi: 10.1002/per.2087. Epub 2017 Jan 6.

2.

Associations between alcohol dehydrogenase genes and alcohol use across early and middle adolescence: Moderation × Preventive intervention.

Cleveland HH, Schlomer GL, Vandenbergh DJ, Wolf PSA, Feinberg ME, Greenberg MT, Spoth RL, Redmond C.

Dev Psychopathol. 2018 Feb;30(1):297-313. doi: 10.1017/S0954579417000633. Epub 2017 May 23.

3.

Impaired quality and efficiency of sleep impairs cognitive functioning in Addison's disease.

Henry M, Ross IL, Wolf PSA, Thomas KGF.

Psychoneuroendocrinology. 2017 Apr;78:237-245. doi: 10.1016/j.psyneuen.2017.02.004. Epub 2017 Feb 11.

PMID:
28235729
4.

Transactions Between Substance Use Intervention, the Oxytocin Receptor (OXTR) Gene, and Peer Substance Use Predicting Youth Alcohol Use.

Cleveland HH, Griffin AM, Wolf PSA, Wiebe RP, Schlomer GL, Feinberg ME, Greenberg MT, Spoth RL, Redmond C, Vandenbergh DJ.

Prev Sci. 2018 Jan;19(1):15-26. doi: 10.1007/s11121-017-0749-5.

5.

Extending Previous cG×I Findings on 5-HTTLPR's Moderation of Intervention Effects on Adolescent Substance Misuse Initiation.

Schlomer GL, Cleveland HH, Feinberg ME, Wolf PSA, Greenberg MT, Spoth RL, Redmond C, Tricou EP, Vandenbergh DJ.

Child Dev. 2017 Nov;88(6):2001-2012. doi: 10.1111/cdev.12666. Epub 2016 Nov 8.

6.

Poor quality of life, depressed mood, and memory impairment may be mediated by sleep disruption in patients with Addison's disease.

Henry M, Wolf PS, Ross IL, Thomas KG.

Physiol Behav. 2015 Nov 1;151:379-85. doi: 10.1016/j.physbeh.2015.08.011. Epub 2015 Aug 7. Erratum in: Physiol Behav. 2016 Mar 1;155:260.

7.

Strategic differentiation and integration of genomic-level heritabilities facilitate individual differences in preparedness and plasticity of human life history.

Woodley Of Menie MA, Figueredo AJ, Cabeza de Baca T, Fernandes HB, Madison G, Wolf PS, Black CJ.

Front Psychol. 2015 Apr 22;6:422. doi: 10.3389/fpsyg.2015.00422. eCollection 2015.

8.

Methodologically sound: Evaluating the psychometric approach to the assessment of human life history [reply to Copping, Campbell, and Muncer, 2014].

Figueredo AJ, Cabeza de Baca T, Black CJ, García RA, Fernandes HB, Wolf PS, Woodley of Menie MA.

Evol Psychol. 2015 Apr 6;13(2):299-338.

9.

Global positioning system technology (GPS) for psychological research: a test of convergent and nomological validity.

Wolf PS, Figueredo AJ, Jacobs WJ.

Front Psychol. 2013 Jun 3;4:315. doi: 10.3389/fpsyg.2013.00315. eCollection 2013.

10.

Preoperative chemotherapy and the risk of hepatotoxicity and morbidity after liver resection for metastatic colorectal cancer: a single institution experience.

Wolf PS, Park JO, Bao F, Allen PJ, DeMatteo RP, Fong Y, Jarnagin WR, Kingham TP, Gönen M, Kemeny N, Shia J, D'Angelica MI.

J Am Coll Surg. 2013 Jan;216(1):41-9. doi: 10.1016/j.jamcollsurg.2012.08.030. Epub 2012 Oct 5.

PMID:
23041049
11.
12.

Impaired humoral response to vaccines among HIV-exposed uninfected infants.

Abramczuk BM, Mazzola TN, Moreno YM, Zorzeto TQ, Quintilio W, Wolf PS, Blotta MH, Morcillo AM, da Silva MT, Dos Santos Vilela MM.

Clin Vaccine Immunol. 2011 Sep;18(9):1406-9. doi: 10.1128/CVI.05065-11. Epub 2011 Jul 20.

13.

Synergistic protection in lung ischemia-reperfusion injury with calcineurin and thrombin inhibition.

McCourtie AS, Merry HE, Wolf PS, FitzSullivan E, Keech JC, Farivar AS, Mulligan MS.

Ann Thorac Surg. 2010 Jun;89(6):1766-71. doi: 10.1016/j.athoracsur.2010.02.068.

14.

Lipopolysaccharide pre-conditioning is protective in lung ischemia-reperfusion injury.

Merry HE, Wolf PS, Fitzsullivan E, Keech JC, Mulligan MS.

J Heart Lung Transplant. 2010 Apr;29(4):471-8. doi: 10.1016/j.healun.2009.11.005. Epub 2009 Dec 31.

15.

Endovascular treatment of massive thoracic aortic thrombus and associated ruptured atheroma.

Wolf PS, Burman HE, Starnes BW.

Ann Vasc Surg. 2010 Apr;24(3):416.e9-416.e12. doi: 10.1016/j.avsg.2009.10.004. Epub 2009 Dec 29.

PMID:
20036509
16.

Endovascular repair of an arteriovenous fistula after intervertebral disk surgery: case report.

Geraghty S, Durham JD, Levy JM, Wolf PS.

J Vasc Interv Radiol. 2009 Sep;20(9):1235-9. doi: 10.1016/j.jvir.2009.06.004. Review.

PMID:
19729135
17.

Alveolar macrophage secretory products effect type 2 pneumocytes undergoing hypoxia-reoxygenation.

McCourtie AS, Farivar AS, Woolley SM, Merry HE, Wolf PS, Mackinnon-Patterson B, Keech JC, Fitzsullivan E, Mulligan MS.

Ann Thorac Surg. 2008 Dec;86(6):1774-9. doi: 10.1016/j.athoracsur.2008.07.071.

18.

Epithelioid sarcoma: the University of Washington experience.

Wolf PS, Flum DR, Tanas MR, Rubin BP, Mann GN.

Am J Surg. 2008 Sep;196(3):407-12. doi: 10.1016/j.amjsurg.2007.07.029. Epub 2008 Apr 24.

PMID:
18436180
19.

Stress-activated protein kinase inhibition to ameliorate lung ischemia reperfusion injury.

Wolf PS, Merry HE, Farivar AS, McCourtie AS, Mulligan MS.

J Thorac Cardiovasc Surg. 2008 Mar;135(3):656-65. doi: 10.1016/j.jtcvs.2007.11.026. Epub 2008 Feb 14. Erratum in: J Thorac Cardiovasc Surg. 2008 Apr;135(4):856.

20.

Poly (ADP) ribose synthetase inhibition in alveolar macrophages undergoing hypoxia and reoxygenation.

McCourtie AS, Farivar AS, Woolley SM, Merry HE, Wolf PS, Szabo C, Mulligan MS.

Exp Mol Pathol. 2008 Apr;84(2):141-4. doi: 10.1016/j.yexmp.2007.11.005. Epub 2007 Dec 7.

PMID:
18206870
21.

Laparoscopic paraesophageal hernia repair.

Wolf PS, Oelschlager BK.

Adv Surg. 2007;41:199-210. Review.

PMID:
17972566
22.

Paroxysmal atrial fibrillation: is anticoagulation justified?

Aboaf AP, Wolf PS.

Hosp Pract (1995). 1996 Dec 15;31(12):11, 15-6, 19. No abstract available.

PMID:
8969675
23.

Paroxysmal atrial fibrillation. A common but neglected entity.

Aboaf AP, Wolf PS.

Arch Intern Med. 1996 Feb 26;156(4):362-7. Review.

PMID:
8607721
24.
25.
26.

Celiprolol, a compound possessing weak alpha 2-adrenergic antagonist properties in the dog.

Mann WS, Sales EF, Van Inwegen RG, Barrett JA, Smith RD, Wolf PS.

Arch Int Pharmacodyn Ther. 1986 Nov;284(1):53-71.

PMID:
2881519
27.

Measurement of oxygen tension in the ischemic myocardium using encased polargraphic oxygen electrodes.

Barrett JA, Lynch VD, Balkon J, Wolf PS.

J Pharmacol Methods. 1986 Jun;15(3):235-43.

PMID:
3086625
28.

The antagonist and partial beta agonist properties of celiprolol in isolated rat cardiac tissue.

Smith RD, Cobuzzi A, Wolf PS, Pruss TP.

Res Commun Chem Pathol Pharmacol. 1986 Feb;51(2):147-61.

PMID:
2870551
29.
30.

Effects of celiprolol in anesthetized dogs with reduced myocardial function.

Wolf PS, Smith RD, Barrett JA, Pruss TP.

J Cardiovasc Pharmacol. 1986;8 Suppl 4:S97-8.

PMID:
2427861
31.

Celiprolol: a new beta adrenoceptor antagonist with novel ancillary properties.

Pruss TP, Khandwala A, Wolf PS, Grebow P, Wong L.

J Cardiovasc Pharmacol. 1986;8 Suppl 4:S29-32. Review.

PMID:
2427849
32.

Celiprolol, a potent cardioselective beta 1-adrenoceptor antagonist with mild alpha 2-adrenoceptor antagonist properties.

Wolf PS, Pruss TP, Rand MJ, Smith RD, Mann WS, Romano DV.

J Hypertens Suppl. 1985 Dec;3(3):S195-7.

PMID:
2908816
33.

The haemodynamic and myocardial contractile effects of celiprolol, atenolol and propranolol in mecamylamine-verapamil pretreated, anaesthetised dogs.

Smith RD, Barrett JA, Wolf PS, Pruss TP.

Br J Clin Pract Suppl. 1985 Jun;42:35-43. No abstract available.

PMID:
2864075
34.

Celiprolol--pharmacological profile of an unconventional beta-blocker.

Wolf PS, Smith RD, Khandwala A, Van Inwegen RG, Gordon RJ, Mann WS, Romano DV, Pruss TP.

Br J Clin Pract Suppl. 1985 Jun;40:5-11. No abstract available.

PMID:
2864065
35.

In vivo anti-allergic and bronchopulmonary pharmacology of REV 3164 in rats and guinea-pigs.

Leibowitz M, Gordon RJ, Wolf PS, Sonnino-Goldman P.

Arch Int Pharmacodyn Ther. 1984 Sep;271(1):135-54.

PMID:
6497506
36.

Angiotensin-converting enzyme inhibitory and antihypertensive activities of pivalopril (RHC 3659-(S)).

Wolf PS, Mann WS, Suh JT, Loev B, Smith RD.

Fed Proc. 1984 Apr;43(5):1322-5.

PMID:
6323222
37.

Preclinical studies of indapamide, a new 2-methylindoline antihypertensive diuretic.

Pruss T, Wolf PS.

Am Heart J. 1983 Jul;106(1 Pt 2):208-11.

PMID:
6869202
38.
39.

Arrhythmias in chronic pulmonary disease.

Wolf PS.

Angiology. 1979 Oct;30(10):676-82.

PMID:
507453
40.

Self-administered chest thump for cardioversion of recurrent ventricular tachycardia.

Conner D, Shander D, Deegan C, Craddock D, Wolf PS, Baum RS.

Chest. 1978 Jun;73(6):877. No abstract available.

PMID:
657867
41.

Spontaneous rupture of a coronary artery with false aneurysm formation. Successful surgical repair.

Frischknecht JK, Shander D, Kurt TL, Wolf PS, Craddock LD.

Chest. 1977 Jul;72(1):123-5.

PMID:
301459
42.

Systemic embolization of the disk occluder of the Wada-Cutter prosthetic valve. A late complication.

Schaeffer JW, Marks SD, Wolf PS, Shander D, Craddock LD, Blount SG Jr.

Chest. 1977 Jan;71(1):44-6.

PMID:
830499
43.

Cardiac asthma--its origin, recognition and management.

Wolf PS.

Ann Allergy. 1976 Oct;37(4):250-4. Review.

PMID:
824980
44.

Antagonism of the behavioral effects of morphine and methadone by narcotic antagonists in the pigeon.

McMillan DE, Wolf PS, Carchman RA.

J Pharmacol Exp Ther. 1970 Nov;175(2):443-58. No abstract available.

PMID:
5481709
45.

The accuracy of pulmonary angiography in assessing resolution of experimental thromboemboli.

Wolf PS, Genton E.

Circulation. 1970 Jan;41(1):59-66. No abstract available.

PMID:
5420634
46.

Dynamics of the splenic erythrocyte reservoir in the dog.

Eisenberg S, Klein GF, Wolf PS.

J Surg Res. 1969 Oct;9(10):595-604. No abstract available.

PMID:
4351977
47.

Clinical experience with counterpulsation in coronary artery disease.

Jacobey JA, Craddock LD, Wolf PS, Beckwitt HJ.

J Thorac Cardiovasc Surg. 1968 Dec;56(6):846-57. No abstract available.

PMID:
5722113
48.

Urokinase therapy in pulmonary thromboembolism.

Genton E, Wolf PS.

Am Heart J. 1968 Nov;76(5):628-37. No abstract available.

PMID:
5698419
49.

Atrial septal defect in patients over 45 years of age. Merits of surgical versus medical therapy.

Wolf PS, Vogel JH, Pryor R, Blount SG Jr.

Br Heart J. 1968 Jan;30(1):115-24. No abstract available.

50.

Experimental pulmonary embolism: effects of urokinase therapy on organizing thrombi.

Genton E, Wolf PS.

J Lab Clin Med. 1967 Aug;70(2):311-25. No abstract available.

PMID:
6029060

Supplemental Content

Support Center